These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8240373)

  • 1. Detection of K-ras codon 12 mutation by polymerase chain reaction and differential dot-blot hybridization in sodium saccharin-treated human RSA cell.
    Suzuki H; Suzuki N
    Biochem Biophys Res Commun; 1993 Oct; 196(2):956-61. PubMed ID: 8240373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of saccharin-induced mutagenicity by interferon-alpha in human RSa cells.
    Suzuki N; Suzuki H
    Cancer Res; 1995 Oct; 55(19):4253-6. PubMed ID: 7671231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
    Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
    Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
    Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-radioactive detection of K-ras mutations by nested allele specific PCR and oligonucleotide hybridization.
    Paranavitana CM
    Mol Cell Probes; 1998 Oct; 12(5):309-15. PubMed ID: 9778456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of PCR-PIRA for screening of a point mutation at codon 12 in K-ras oncogene obtained from paraffin embedded tissue sections.
    Chewawiwat N; Lulitanond V; Nimmanahaeminda K; Thamprasert K; Nicomrat D; Ponglikitmongkol M
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():329-32. PubMed ID: 8629136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients.
    Rosell R; Li S; Skacel Z; Mate JL; Maestre J; Canela M; Tolosa E; Armengol P; Barnadas A; Ariza A
    Oncogene; 1993 Sep; 8(9):2407-12. PubMed ID: 8395679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ras mutations in 2-acetylaminofluorene-induced lung and liver tumors from C3H/HeJ and (C3H x A/J)F1 mice.
    Wang Y; Wang Y; Stoner G; You M
    Cancer Res; 1993 Apr; 53(7):1620-4. PubMed ID: 8453632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction.
    Stratton MR; Fisher C; Gusterson BA; Cooper CS
    Cancer Res; 1989 Nov; 49(22):6324-7. PubMed ID: 2680062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetics of malignant insulinoma.
    Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
    Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approaching real-time molecular diagnostics: single-pair fluorescence resonance energy transfer (spFRET) detection for the analysis of low abundant point mutations in K-ras oncogenes.
    Wabuyele MB; Farquar H; Stryjewski W; Hammer RP; Soper SA; Cheng YW; Barany F
    J Am Chem Soc; 2003 Jun; 125(23):6937-45. PubMed ID: 12783546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenes in multiple myeloma: point mutation of N-ras.
    Paquette RL; Berenson J; Lichtenstein A; McCormick F; Koeffler HP
    Oncogene; 1990 Nov; 5(11):1659-63. PubMed ID: 2267133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative detection of mutant alleles of the K-ras gene with minor groove binder-conjugated fluorogenic DNA probes.
    Itabashi T; Maesawa C; Uchiyama M; Higuchi T; Masuda T
    Int J Oncol; 2004 Mar; 24(3):687-96. PubMed ID: 14767554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of point mutation of N-ras oncogene in bone marrow cells with aplastic anemia.
    Shinohara K; Yujiri T; Kamei S; Ayame H; Tanaka M; Ando S; Tajiri M
    Int J Cell Cloning; 1992 Mar; 10(2):94-8. PubMed ID: 1545154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of infrequent and multiple K-ras mutations in human tumors and tumor-adjacent tissues.
    Keohavong P; Zhu D; Whiteside TL; Swalsky P; Bakker A; Elder EM; Siegfried JM; Srivastava S; Finkelstein SD
    Anal Biochem; 1997 May; 247(2):394-403. PubMed ID: 9177704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
    Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
    Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative enriched PCR (QEPCR), a highly sensitive method for detection of K-ras oncogene mutation.
    Ronai Z; Minamoto T
    Hum Mutat; 1997; 10(4):322-5. PubMed ID: 9338587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Ki-ras mutations by PCR and differential hybridization and of p53 mutations by SSCP analysis in endoscopically obtained lavage solution from patients with long-standing ulcerative colitis.
    Lang SM; Heinzlmann M; Stratakis DF; Teschauer W; Loeschke K
    Am J Gastroenterol; 1997 Dec; 92(12):2166-70. PubMed ID: 9399746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of K-ras oncogene mutations by polymerase chain reaction-based ligase chain reaction.
    Lehman TA; Scott F; Seddon M; Kelly K; Dempsey EC; Wilson VL; Mulshine JL; Modali R
    Anal Biochem; 1996 Aug; 239(2):153-9. PubMed ID: 8811898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on ras oncogene activation in endometrial carcinoma.
    Fujimoto I; Shimizu Y; Hirai Y; Chen JT; Teshima H; Hasumi K; Masubuchi K; Takahashi M
    Gynecol Oncol; 1993 Feb; 48(2):196-202. PubMed ID: 8428691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.